Nalbuphine vs. Pethidine Efficacy in Oocyte Retrieval: A Randomized Controlled Trial

94 participants were randomized in a double-blinded trial comparing Nalbuphine and Pethidine for pain relief during oocyte retrieval. Results show Nalbuphine demonstrated non-inferior analgesia at 0 and 2 hours postoperatively and significantly lower pain scores at 6 hours. The dataset, authored by Pitchapa Em-eam and last updated in 2026, contains the study's efficacy and safety outcomes.

Use Cases

• Compare postoperative pain scores based on visual analogue scale measurements mentioned in the description
• Analyze side effect profiles based on reported rates of nausea, vomiting, dizziness, and tachycardia
• Evaluate patient cooperation and recovery times based on operator scores and recorded times
• Assess the impact of analgesic regimen on oocyte retrieval outcomes based on the number and quality of oocytes

Strengths

• Data originates from a double-blinded, randomized controlled trial with 94 participants, a standard for clinical evidence.
• Primary and secondary outcomes are clearly defined, including pain scores at multiple time points and multiple safety metrics.
• The dataset is shared under a permissive CC-BY-4.0 license, facilitating reuse.

Limitations

• Row count and column-level documentation are unknown, which may limit suitability assessment.
• The dataset is very small at 16.2 KB, indicating limited scope.
• Data may reflect bias inherent to the specific clinical trial's participant population and setting.

Provenance

Source

figshare

Collection Method

Collected from a non-inferiority, double-blinded, randomized controlled trial (RCT).

Freshness

Last updated 2026-04-30 05:39:33; freshness should be verified.